Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 3c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.03 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• CDW to acquire data and AI firm Lovelytics for $525 million
• Argan (AGX) Tops Q2 EPS by 110c